{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:28:06Z","timestamp":1767929286035,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T00:00:00Z","timestamp":1189036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T00:00:00Z","timestamp":1189036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1038\/sj.leu.2404936","type":"journal-article","created":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T09:16:59Z","timestamp":1189070219000},"page":"2506-2511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice"],"prefix":"10.1038","volume":"21","author":[{"given":"J-S","family":"Roy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Van Themsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Demers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Opdenakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"St-Pierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,6]]},"reference":[{"key":"BF2404936_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/35077241","volume":"411","author":"LA Liotta","year":"2001","unstructured":"Liotta LA, Kohn EC . The microenvironment of the tumour-host interface. Nature 2001; 411: 375\u2013379.","journal-title":"Nature"},{"key":"BF2404936_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad M, Werb Z . New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161\u2013174.","journal-title":"Nat Rev Cancer"},{"key":"BF2404936_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature03096","volume":"432","author":"MA Bhowmick","year":"2004","unstructured":"Bhowmick MA, Neilson EG, Moses HL . Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 332\u2013337.","journal-title":"Nature"},{"key":"BF2404936_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc1821","volume":"6","author":"CM Overall","year":"2006","unstructured":"Overall CM, Kleifeld O . Tumour microenvironment\u2014opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 2006; 6: 227\u2013239.","journal-title":"Nat Rev Cancer"},{"key":"BF2404936_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z . Inflammation and cancer. Nature 2002; 420: 860\u2013867.","journal-title":"Nature"},{"key":"BF2404936_CR6","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-04-3770","volume":"65","author":"S Jodele","year":"2005","unstructured":"Jodele S, Chantrain CF, Blavier L, Lutzko C, Crooks GM, Shimada H et al. The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res 2005; 65: 3200\u20133208.","journal-title":"Cancer Res"},{"key":"BF2404936_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ccr.2005.05.019","volume":"7","author":"LE Littlepage","year":"2005","unstructured":"Littlepage LE, Egeblad M, Werb Z . Coevolution of cancer and stromal cellular responses. Cancer Cell 2005; 7: 499\u2013500.","journal-title":"Cancer Cell"},{"key":"BF2404936_CR8","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.V94.6.2080","volume":"94","author":"AE Kossakowska","year":"1999","unstructured":"Kossakowska AE, Edwards DR, Prusinkiewicz C, Zhang MC, Guo D, Urbanski SJ . Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood 1999; 94: 2080\u20132089.","journal-title":"Blood"},{"key":"BF2404936_CR9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/cncr.11905","volume":"100","author":"K Sakata","year":"2004","unstructured":"Sakata K, Satoh M, Someya M, Asanuma H, Nagakura H, Oouchi A et al. Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma. Cancer 2004; 100: 356\u2013365.","journal-title":"Cancer"},{"key":"BF2404936_CR10","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1182\/blood.V89.5.1708","volume":"89","author":"M Stetler-Stevenson","year":"1997","unstructured":"Stetler-Stevenson M, Mansoor A, Lim M, Fukushima P, Kerhl J, Marti G et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood 1997; 89: 1708\u20131715.","journal-title":"Blood"},{"key":"BF2404936_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1182\/blood.V99.4.1341","volume":"99","author":"N Mori","year":"2002","unstructured":"Mori N, Sato H, Hayashibara T, Senba M, Hayashi T, Yamada Y et al. Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness. Blood 2002; 99: 1341\u20131349.","journal-title":"Blood"},{"key":"BF2404936_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/(SICI)1097-0215(19970328)71:1<71::AID-IJC13>3.0.CO;2-C","volume":"71","author":"F Aoudjit","year":"1997","unstructured":"Aoudjit F, Esteve PO, Desrosiers M, Potworowski EF, St-Pierre Y . Gelatinase B (MMP-9) production and expression by stromal cells in the normal and adult thymus and experimental thymic lymphoma. Int J Cancer 1997; 71: 71\u201378.","journal-title":"Int J Cancer"},{"key":"BF2404936_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<743::AID-IJC19>3.0.CO;2-6","volume":"82","author":"F Aoudjit","year":"1999","unstructured":"Aoudjit F, Masure S, Opdenakker G, Potworowski EF, St-Pierre Y . Gelatinase B (MMP-9), but not its inhibitor (TIMP-1), dictates the growth rate of experimental thymic lymphoma. Int J Cancer 1999; 82: 743\u2013747.","journal-title":"Int J Cancer"},{"key":"BF2404936_CR14","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1158\/0008-5472.CAN-04-3570","volume":"65","author":"A Kruger","year":"2005","unstructured":"Kruger A, Arlt MJ, Gerg M, Kopitz C, Bernado MM, Chang M et al. Antimetastatic activity of a novel mechanism-based gelatinase inhibitor. Cancer Res 2005; 65: 3523\u20133526.","journal-title":"Cancer Res"},{"key":"BF2404936_CR15","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1172\/JCI6886","volume":"104","author":"B Dubois","year":"1999","unstructured":"Dubois B, Masure S, Hurtenbach U, Paemen L, Heremans H, Van den Oord J . Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest 1999; 104: 1507\u20131515.","journal-title":"J Clin Invest"},{"key":"BF2404936_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.leu.2402870","volume":"17","author":"S Moisan","year":"2003","unstructured":"Moisan S, Demers M, Mercier J, Magnaldo T, Potworowski EF, St-Pierre Y . Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype. Leukemia 2003; 17: 751\u2013759.","journal-title":"Leukemia"},{"key":"BF2404936_CR17","first-page":"1325","volume":"27","author":"HS Kaplan","year":"1967","unstructured":"Kaplan HS . On the natural history of the murine leukemias: presidential address. Cancer Res 1967; 27: 1325\u20131340.","journal-title":"Cancer Res"},{"key":"BF2404936_CR18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1182\/blood.V95.1.314","volume":"95","author":"M Lalancette","year":"2000","unstructured":"Lalancette M, Aoudjit F, Potworowski EF, St-Pierre Y . Resistance of ICAM-1-deficient mice to metastasis overcome by increased aggressiveness of lymphoma cells. Blood 2000; 95: 314\u2013319.","journal-title":"Blood"},{"key":"BF2404936_CR19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/10409230290771546","volume":"37","author":"PE Van den Steen","year":"2002","unstructured":"Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G . Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 2002; 37: 375\u2013536.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"BF2404936_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ijc.2910240208","volume":"24","author":"M Lieberman","year":"1979","unstructured":"Lieberman M, Decleve M, Ricciardi-Castagnoli P, Boniver J, Finn OJ, Kaplan HS . Establishment, characterization and virus expression of cell lines derived from radiation- and virus-induced lymphomas of C57BL\/Ka mice. Int J Cancer 1979; 24: 168\u2013177.","journal-title":"Int J Cancer"},{"key":"BF2404936_CR21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1182\/blood.V91.2.623","volume":"91","author":"F Aoudjit","year":"1998","unstructured":"Aoudjit F, Potworowski EF, St-Pierre Y . The metastatic characteristics of murine lymphoma cell lines in vivo are manifested after target organ invasion. Blood 1998; 91: 623\u2013629.","journal-title":"Blood"},{"key":"BF2404936_CR22","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1158\/0008-5472.CAN-05-0134","volume":"65","author":"M Demers","year":"2005","unstructured":"Demers M, Magnaldo T, St-Pierre Y . A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression. Cancer Res 2005; 65: 5010\u20135205.","journal-title":"Cancer Res"},{"key":"BF2404936_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/35036374","volume":"2","author":"G Bergers","year":"2000","unstructured":"Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2: 737\u2013744.","journal-title":"Nat Cell Biol"},{"key":"BF2404936_CR24","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/sj.leu.2403331","volume":"18","author":"I Van de Broek","year":"2004","unstructured":"Van de Broek I, Asosingh K, Allegaert T, Leleu X, Facon T, Vanderkerken K et al. Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor. Leukemia 2004; 18: 976\u2013982.","journal-title":"Leukemia"},{"key":"BF2404936_CR25","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1038\/sj.onc.1207616","volume":"23","author":"SS Lakka","year":"2004","unstructured":"Lakka SS, Gondi CS, Yanamandra M, Olivero WC, Dinh DH, Gujrati M . Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 2004; 23: 4681\u20134689.","journal-title":"Oncogene"},{"key":"BF2404936_CR26","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/jnci\/94.15.1134","volume":"94","author":"S Huang","year":"2002","unstructured":"Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 2002; 94: 1134\u20131142.","journal-title":"J Natl Cancer Inst"},{"key":"BF2404936_CR27","doi-asserted-by":"publisher","first-page":"10959","DOI":"10.1158\/0008-5472.CAN-05-2228","volume":"65","author":"EI Deryugina","year":"2005","unstructured":"Deryugina EI, Zjilstra A, Partridge JJ, Kupriyanova TA, Madsen MA, Papagianakopoulos T et al. Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination. Cancer Res 2005; 65: 10959\u201310969.","journal-title":"Cancer Res"},{"key":"BF2404936_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0092-8674(00)00139-2","volume":"103","author":"LM Coussens","year":"2000","unstructured":"Coussens LM, Tinkle CL, Hanahan D, Werb Z . MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000; 103: 481\u2013490.","journal-title":"Cell"},{"key":"BF2404936_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/ng1249","volume":"35","author":"M Balbin","year":"2003","unstructured":"Balbin M, Fueyo A, Tester AM, Pendas AM, Pitiot AS, Astudillo A et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 2003; 35: 252\u2013257.","journal-title":"Nat Genet"},{"key":"BF2404936_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","volume":"6","author":"KE de Visser","year":"2006","unstructured":"de Visser KE, Eichten A, Coussens LM . Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006; 6: 24\u201337.","journal-title":"Nat Rev Cancer"},{"key":"BF2404936_CR31","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.1158\/0008-5472.CAN-04-0297","volume":"66","author":"AM Houghton","year":"2006","unstructured":"Houghton AM, Grisolano JL, Baumanm ML, Kobayashi DK, Hautamaki RD, Nehring LC . Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. Cancer Res 2006; 66: 6149\u20136155.","journal-title":"Cancer Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404936","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:30:41Z","timestamp":1648780241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,6]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["BF2404936"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404936","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,6]]},"assertion":[{"value":"9 January 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}